Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a growing $22.8 billion therapeutics market. Read the IPO report here ...

Daddy had once been 6 feet tall and 155 pounds. Now at 5 foot 8 and just 123 pounds, he weighed less than anyone else in the ...

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it. And, as University of South Florida pulmonologist Dr. Jose ...

Mediar Therapeutics is planning to launch a Phase 2 clinical trial in the first half of 2025 to test its IPF therapy MTX-463.

Virtual choir program founder Ashley Ballou-Bonnema shares her selfless story on living with and advocating for a life with the chronic disease.

Its Respiratory Advisory Committee has recommended funding with high priority for children aged two to five years. The medicine is currently only funded for ages six and up Cystic Fibrosis NZ CEO Lisa ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

I was born in Adelaide, Australia, and I lived there until I was 10. My parents were from Ireland. They had emigrated to Australia in the 1960s, and we moved back to Ireland in the 1980s. When we came ...

The game ostensibly replaces the Empire Challenge, an event that was organized, funded and run by the Boomer Esiason ...

Crown Princess Mette-Marit of Norway was photographed looking chic today as she visited the International Library Of Fashion ...

Katie Price shared a health update with fans after revealing she has undergone checks on her lungs. The former glamour model ...